COVID-19 Rapid Test At-Home Kit, Box of 2
- Authorized for nonprescription home use
- Self-collected anterior nasal swab specimens
- Suitable for individuals aged 2 years and older
- Intended for qualitative detection of SARS-CoV-2
- FDA Emergency Use Authorization (EUA) only
- Test twice over two or three days
- Sold as a Box of 2
Description
FOR FDA EMERGENCY USE AUTHORIZATION (EUA) ONLY. The QuickVue At-Home OTC COVID-19 Test is intended for the qualitative detection of the nucleocapsid protein antigen from SARS-CoV-2 from individuals with or without symptoms or other epidemiological reasons to suspect COVID-19 when tested twice over two or three days with at least 24 hours and no more than 36 hours between tests.
This home test is authorized for nonprescription home use with self-collected (unobserved) direct anterior nasal (NS) swab specimens from individuals aged 14 years and older or with adult-collected anterior NS samples from individuals aged 2 years or older. This home test has not been FDA cleared or approved, but has been authorized by the FDA under an Emergency Use Authorization (EUA) for the detection of proteins from SARS-CoV-2, not for any other viruses or pathogens.
This home test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless authorization is terminated or revoked sooner.
Item # | 204022 |
MPN | 20402 |
Manufacturer | Quidel |
Type | Nasal Swab Sample |
UOM Packaging | Box of 2 |
UOM | BX |
Test Format | Strip |
Country of Origin | USA |
Number of Tests | 2 Tests |
CLIA | Clia Waived |
Reading Type | Visual Read |
Test Type | At-Home OTC COVID-19 Test |
Time to Results | 10 minutes |